Description Des Troubles Respiratoires Chez Les Patients Suivis Pour Une Sclérose en Plaques (SEP) sévère
RespiMuS
2 other identifiers
interventional
70
1 country
1
Brief Summary
The purpose of this study is to describe respiratory disorders in patients with severe multiple sclerosis (EDSS from 6.5).
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for not_applicable multiple-sclerosis
Started Jan 2018
Typical duration for not_applicable multiple-sclerosis
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
October 31, 2017
CompletedFirst Posted
Study publicly available on registry
November 13, 2017
CompletedStudy Start
First participant enrolled
January 11, 2018
CompletedPrimary Completion
Last participant's last visit for primary outcome
November 6, 2020
CompletedStudy Completion
Last participant's last visit for all outcomes
November 6, 2020
CompletedDecember 10, 2025
March 1, 2025
2.8 years
October 31, 2017
December 3, 2025
Conditions
Outcome Measures
Primary Outcomes (1)
Polysomnography
presence of phasic activation of respiratory muscles
Baseline only_during one night
Secondary Outcomes (8)
Respiratory function testing
Baseline only
Respiratory function testing
Baseline only
Respiratory function testing
Baseline only
Respiratory function testing
Baseline only
Respiratory function testing
Baseline only
- +3 more secondary outcomes
Study Arms (1)
Patients with severe MS
OTHERpolysomnography and functional pulmonary testings.
Interventions
During polysomnographia and functional pulmonary testing, signs of diaphragmatic dysfunction responsible for respiratory disorders will be searched.
Eligibility Criteria
You may qualify if:
- Diagnosis criteria of multiple sclerosis (MS) fulfilling revised McDonald criteria (2010)
- EDSS score from 6.5
- no relapse during the 3 last months
- Informed consent prior to any study procedure
You may not qualify if:
- Any severe Chronic Obstructive Pulmonary Disease (III or IV)
- Pregnancy or woman with childbearing potential
- contraindication to MRI
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Département de Neurologie-Groupe Hospitalier Pitié-Salpêtrière
Paris, Paris, 75013, France
Related Publications (1)
Zeidan S, Redolfi S, Papeix C, Bodini B, Louapre C, Arnulf I, Maillart E. Unexpected REM sleep excess associated with a pontine lesion in multiple sclerosis. J Clin Sleep Med. 2021 May 1;17(5):1117-1119. doi: 10.5664/jcsm.9114.
PMID: 33538688RESULT
MeSH Terms
Conditions
Interventions
Condition Hierarchy (Ancestors)
Intervention Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Maillart Elisabeth, MD
Hopital de la Pitié Salpétrière
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- NA
- Masking
- NONE
- Purpose
- OTHER
- Intervention Model
- SINGLE GROUP
- Sponsor Type
- OTHER GOV
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
October 31, 2017
First Posted
November 13, 2017
Study Start
January 11, 2018
Primary Completion
November 6, 2020
Study Completion
November 6, 2020
Last Updated
December 10, 2025
Record last verified: 2025-03